A cross-border initiative led by Dr. Nir London at the Weizmann Institute of Science (Israel) has brought together a wide range of international players in the drug development process – from academia to biotech and contract research organizations, to specialized software companies – to accelerate the development of a drug for COVID-19. Enamine (Ukraine), one of the largest chemical vendors in the world, contributes towards the development of a drug against COVID-19 within this initiative.